The pyruvate kinase activator mitapivat reduces hemolysis and improves anemia in a β-thalassemia mouse model-Reference-Cited by-同舟云学术

The pyruvate kinase activator mitapivat reduces hemolysis and improves anemia in a β-thalassemia mouse model

Published:2021-04-06 Issue: Volume: Page:
ISSN:1558-8238
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Matte Alessandro,Federti Enrica,Kung Charles,Kosinski Penelope A.,Narayanaswamy Rohini,Russo Roberta^ORCID,Federico Giorgia,Carlomagno Francesca,Desbats Maria Andrea,Salviati Leonardo^ORCID,Leboeuf Christophe^ORCID,Valenti Maria Teresa,Turrini Francesco,Janin Anne,Yu Shaoxia,Beneduce Elisabetta,Ronseaux Sebastien,Iatcenko Iana^ORCID,Dang Lenny^ORCID,Ganz Tomas^ORCID,Jung Chun-Ling,Iolascon Achille,Brugnara Carlo^ORCID,De Franceschi Lucia

Funder

Agios Pharmaceuticals, Inc.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

http://www.jci.org/articles/view/144206/files/pdf

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preliminary screening of biomarkers and drug candidates in a mouse model of β-thalassemia based on quasi-targeted metabolomics;Frontiers in Physiology;2024-08-23

2. Novel therapeutic approaches in thalassemias, sickle cell disease, and other red cell disorders;Blood;2024-08-22

3. Anemia and iron overload as prognostic markers of outcomes in β-thalassemia;Expert Review of Hematology;2024-07-26

4. Disease burden, management strategies, and unmet needs in α‐thalassemia due to hemoglobin H disease;American Journal of Hematology;2024-07-22

5. Mitochondrial regulation of erythropoiesis in homeostasis and disease;British Journal of Haematology;2024-06-30